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A commentary on
Potent engineered PLGA nanoparticles by
virtue of exceptionally high chemothera-
peutic loadings
by Enlow, E. M., Luft, J. C., Napier, M. E.,
and DeSimone, J. M. (2011). Nano Lett.
11, 808–813.
Polymers have been used since decades
as carriers for chemotherapeutic drugs.
Among the various controlled release
polymer technologies PLGA [poly(lactic
acid-co-glycolic acid)] has the greatest
clinical impact till date. Precisely engi-
neered PLGA’s is the need of the hour
(Figure 1). For the first time, Elizabeth
Enlow and colleagues have come out with
a new strategy of fabricating PLGA via the
PRINT technology.
Traditional methods of fabricat-
ing PLGA nanoparticles are emul-
sions, precipitations, spray drying,
Figure 1 |
ultrasonication, and flow focusing. The
effects of these process parameters on par-
ticle properties such as solvent, emulsifier,
and particle composition affecting particle
size, cargo release, and cargo encapsula-
tion are the important issues. Poor encap-
sulation efficiency resulting in lower drug
loadings limits the particles therapeuti-
cally effective dose is a challenge. So, is
there a way out? Yes. The authors used the
particle replication in non-wetting tem-
plates (PRINT) technology, a soft lithog-
raphy platform based on a perfluorinated
polyether elastomer which has the unique
ability to fabricate particles of versatile
sizes, shapes, and surface textures indepen-
dent of process parameters. The PRINT
process allows same particle geometry to
be created with a variety of polymer
molecular weights, polymer lactic acid
to glycolic acid ratios, solvent systems,
stabilizers, and cargos unlike the tradi-
tional techniques. The sizes and shapes
can be used to affect cell uptake, biodis-
tribution, and flow characteristics. Cargos
can be easily encapsulated without process
modifications. The authors have demon-
strated high and efficient drug loadings
up to 40% (w/w) with encapsulation effi-
ciencies >90% with the PLGA PRINT
nanoparticles of a potent chemotherapeu-
tic drug Docetaxel. In comparison to this,
maximum Docetaxel loading was 15%
with encapsulation varying widely depen-
dent on particular fabrication method and
specific parameters used with the tradi-
tional methods (Enlow et al., 2011). The
PRINT process has tight control over par-
ticle composition retaining the particle’s
physical characteristics, homogenous size,
and shape, morphology as well as its
consistency.
The authors tested the effectiveness
of these PLGA PRINT nanoparticles by
exposing them to Ovarian carcinoma
cells, SKOV3 in vitro. The findings have
shown higher toxicity with high encap-
sulation of Docetaxel which can be
delivered intact to its desired cellular
location in comparison to particles
with lower drug loadings and the clin-
ical formulation of Docetaxel, Taxotere.
Further research is needed to estab-
lish its enhanced therapeutic potential
in vivo at a lower dose and higher
loadings.
The PRINT tailored PLGA drug deliv-
ery system is a very significant advance
with the greater ability to encapsulate
high therapeutic loadings efficiently, to
protect cargo, program release kinetics,
design multifunctionality, and compat-
ibility beyond doubt. Therefore, devel-
oping this PRINT engineered polymeric
PLGA is a goldmine as nano-carriers for
chemotherapeutic drugs.
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